Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease

ConditionFabry Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNúcleo de Apoio à Investigação Clínica - FMUP

About this trial

In this work, we address the understanding of the signaling pathways involved in cardiac remodeling in human SCD through molecular imaging analysis with a fibrosis marker. Furthermore, we emphasize characterizing the cardiac remodeling process by analyzing proteomic data from SCD myocardial biopsies and by analyzing the profile of microRNAs associated with hypertrophic cardiomyopathy and their diagnostic and prognostic value.

Eligibility criteria

Qualifiers

Adult patients, over 18 years of age;

Diagnosis of Fabry disease

Disqualifiers

Refusal to participate in the study

Trial design

Treatments tested in this trial

  • PET scan of 68Ga-FAPI

Treatment groups

20 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Núcleo de Apoio à Investigação Clínica - FMUP

Lead sponsor

Universidade do Porto

Sponsor institution

Universidade do Porto

Collaborator

SOFIE

Collaborator

GE Healthcare

Collaborator